This is not a fundamental look at any of these stocks, but just a quick update on my personal portfolio. Like you, I have many priorities in my life… and some of those priorities changed a bit over the last week or two, so we’re considering some real estate transactions that make it important for […]
Articles
I wrote a short note to you last weekend while I was attending the Berkshire Hathaway annual meeting, and as part of that I noted that I had taken some profits on several of my time-sensitive gold positions, including some warrants on Brazil Resources and call options on Sandstorm Gold, among others. I didn’t get […]
We’re just about shut down here at Stock Gumshoe HQ for the market holiday today, but I do have some updated thoughts and musings for you about a few of the companies I own and write about with some regularity: Leucadia (LUK), Medical Properties Trust (MPW), and Fosun (FOSUF). And I should also update you […]
Brad Hoppmann at Uncommon Wisdom Daily is pitching his “entry level” Cash Flow Kings newsletter by promising two “secret” investments that will help you profit from the “Fall of the Wall” … so what’s he talking about? Well, the “Wall” is, of course, his metaphor for what a lot of folks, particularly the small investors […]
Each year I go through all of the stocks that I either own personally or have brought to the attention of the Irregulars (there’s quite a bit of overlap on those lists), and I make sure to update my thoughts and opinion on that stock in an organized and, hopefully, disciplined way — that helps […]
We originally covered a teaser ad very similar to this on October 30, 2013. The ad promising a “Next Berkshire Hathaway” is circulating again and generating more questions from our readers, so I’m re-analyzing it here for your information. The ad has been slightly updated with new numbers over the years, and this article has […]
Several stocks I own or write a lot about have some news (or have made some big moves) in the last week or two, so I’ll focus on answering some of the reader questions and updating my opinion on those this week. Altius released their results, so we’ll take a gander at those since lots […]
I’m feeling a little bit old today because my fourth baby, Stock Gumshoe, just celebrated its eighth birthday. Eight years of solving teasers, sharing thoughts, and defusing marketing hype… and it’s still such a cute little fella! I certainly never expected this to grow and get the attention of so many people when I sat […]
More “Contrarian Bonanza” picks, you ask? Well of course! There are several new teaser ads stacking up in the Thinkolator’s inbox, but before we get to those … let’s close the book on the “contrarian bonanza” picks from the Weiss folks as they tease their Million-Dollar Contrarian Portfolio. There are three left of the seven […]
I don’t think I’ve ever written a word about Charles Mizrahi, but he’s been around for a while as a respected value stock picker with at least one newsletter under his name … and he’s got a teaser ad out now that’s getting the attention of Gumshoe readers, so I thought it an opportune time […]
This is a follow-up to our look at the “Pasadena Secret Investment Society,” which teased us with five other holding companies that the Porter Stansberry Investment Advisory thinks are great investments. In the words of Stansberry & Associates, “If you’d like to make a small fortune in America today, we believe the only safe and […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I believe its the same pitch Travis has already wrote about, Bellicum Pharmaceuticals https://www.stockgumshoe.com/r...
A friend is someone with whom you dare to be yourself. ~ Frank Crane Immunotherapy has been the most exciting advance...
BELLICUM PHARMACEUTICALS INC COM BLCM: NASDAQ...
I'm new to Gumshoe and this thread. Just wanted to ask if anyone has knowledge of Lexagene Holdings Inc. (LXXGF) and/or...
Hey gumshoe bellicum pharmaceuticals was supposed to announce a licensing deal today either with Novartis or glaxo Smith...
See the following article at Yahoo.com Finance: Here's Why Bellicum Pharmaceuticals Fell as Much as 13.8% Today...
This is just now: BLCM Bellicum Pharmaceuticals Inc $0.20 (1.52%) $20.00 $49.05 (3.82%) MBRX Moleculin...
The BLCM goes up again today: BLCM Bellicum Pharmaceuticals Inc 100 $1,284.95 $12.85 $13.55 $0.19 (1.42%) ...
New Clinical Trial Review: Leukemia Patients Treated by Bellicum Pharmaceuticals -- 91% remission, 94% Survival (median ...
Bellicum Pharmaceuticals Inc BLCM....
Annemarie Moseley Bellicum Pharmaceuticals Inc.,Houston,United States Speaker of (S146) BPX-501 DONOR T CELL INFUSI...
John Weinberg Bellicum Pharmaceuticals Inc.,Houston,United States Speaker of (S146) BPX-501 DONOR T CELL INFUSION (...
Nov. 1, 2016-- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM) and Ospedale Pediatrico Bambino Gesù (OPBG), a leading Euro...
I've noticed some confusion about the nature of the $388,000 in this thread. The $388,000 is in relation to their 2016 f...
Maybe helpful? Maybe someone can help confirm relevance? All accepted abstracts of the 22nd Congress are now publishe...
This is a bit of an aside, but I've been thinking of putting together a tracking index of the biotechs followed here. W...
Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and deve...
Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and deve...
A take on Juno Therapeutics (JUNO) and Bellicum Pharmaceuticals (BLCM). http://www.fool.com/investing/general/2015/01/2...
RE:BLCM Bellicum Pharmaceuticals Announces Successful Dosing of First Patient Cohort With BPX-501 T Cells Following Hap...
KSS the Magical Marvelous (De)Mystifying Tour Guide: You mentioned Bellicum Pharmaceuticals ($BLCM) as, "a new immuno...
Bellicum Pharmaceuticals ($BLCM) is a new immuno-onc play with designs on T-cell mediated tumor kill by distinct approac...